Trends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, Canada

被引：22
|
作者：
Labbé, AC [1 ]
Bourgault, AM [1 ]
Vincelette, J [1 ]
Turgeon, PL [1 ]
Lamothe, F [1 ]
机构：
[1] CHU Montreal, Dept Microbiol Med & Infectiol, Montreal, PQ H2X 3J4, Canada
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1999年 / 43卷 / 10期
关键词：
D O I：
10.1128/AAC.43.10.2517
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The objective of the present study was to analyze the susceptibility profiles of 911 clinical strains of the Bacteroides fragilis group isolated from 1992 to 1997 in our institution in order to monitor susceptibility changes over time. Whereas the rates of resistance to metronidazole, imipenem, piperacillin-tazobactam, ticarcillin-clavulanic acid, penicillin, piperacillin, and cefoxitin remained essentially unchanged, there was a significant increase in the rates of resistance to clindamycin, which rose from 8.2% in 1992 to 19.7% in 1997 (P < 0.0004).
引用
收藏
页码：2517 / 2519
页数：3
相关论文
共 50 条
  • [41] Antimicrobial resistance of strains of the Bacteroides fragilis group isolated from the intestinal tract of children and adults in Brazil
    Avelar, KES
    Vieira, JMBD
    Antunes, LCM
    Lobo, LA
    Antunes, ENF
    Domingues, RMCP
    Ferreira, MCS
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (02) : 129 - 134
  • [42] National survey on the susceptibility of Bacteroides fragilis group:: Report and analysis of trends for 1997-2000
    Snydman, DR
    Jacobus, NV
    McDermott, LA
    Ruthazer, R
    Goldstein, EJC
    Finegold, SM
    Harrell, LJ
    Hecht, DW
    Jenkins, SG
    Pierson, C
    Venezia, R
    Rihs, J
    Gorbach, SL
    CLINICAL INFECTIOUS DISEASES, 2002, 35 : S126 - S134
  • [43] Genotyping of multi drug resistant Bacteroides fragilis group of clinical isolates from mangalore, south India
    Colney, Zomuanpuii
    Antony, Beena
    Kanthaje, Shruthi
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2021, 39 (01) : 19 - 23
  • [44] Resistance to metronidazole among Bacteroides fragilis group strains from humans and marmosets: Comparative study
    Pestana, ACNR
    Ribeiro, RN
    Diniz, CG
    Farias, LM
    Carvalho, MAR
    CLINICAL INFECTIOUS DISEASES, 1997, 25 : S279 - S280
  • [45] Antimicrobial resistance pattern of the Bacteroides fragilis group strains isolated at a teaching hospital in China
    Wu, Zhi Cheng
    Feng, Hong Xin
    Wu, Lin
    Zhang, Meng
    Gu, Zheng
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2025, 72 (01) : 59 - 67
  • [46] Antibiotic resistance and adhesion potential of Bacteroides fragilis clinical isolates from Cape Town, South Africa
    Galvao, B. P. G. V.
    Meggersee, R. L.
    Abratt, V. R.
    ANAEROBE, 2011, 17 (04) : 142 - 146
  • [47] Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000
    Low, DE
    de Azavedo, J
    Weiss, K
    Mazzulli, T
    Kuhn, M
    Church, D
    Forward, K
    Zhanel, G
    Simor, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) : 1295 - 1301
  • [48] Transfer of clindamycin resistance between Bacteroides fragilis group strains isolated from clinical specimens
    de Carvalho, CBM
    Moreira, JLB
    Ferreira, MCS
    REVISTA DE MICROBIOLOGIA, 1998, 29 (03): : 183 - 186
  • [49] Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species
    Aldridge, KE
    Ashcraft, D
    Cambre, K
    Pierson, CL
    Jenkins, SG
    Rosenblatt, JE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) : 1238 - 1243
  • [50] Molecular study on metronidazole resistance in Bacteroides fragilis group isolates from a South Indian tertiary care center
    Jahan, Lulu
    Biswas, Rakhi
    ANAEROBE, 2023, 80
12345